Steadymed ltd. (STDY)
CashFlow / TTM
Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Mar'14
Cash flows from operating activities:
Net loss

-16,924

-15,001

-23,205

0

0

0

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-25,920

-25,689

-24,971

0

0

0

0

Adjustments required to reconcile net loss to net cash used in operating activities:
Stock-based compensation

1,276

1,074

940

954

930

870

833

800

749

700

583

0

0

0

0

Depreciation and impairment of fixed assets

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

620

543

442

385

339

0

0

0

0

Accrued severance pay, net

0

0

-

0

0

0

-

11

21

22

3

0

0

0

-

Accrued severance pay, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of discount on loan

-

-

-

-

-

-

-

-

-

-

11

0

0

0

0

Re-evaluation of fair value of warrants to purchase Ordinary Shares

-5,955

-6,066

2,448

0

0

0

-

-

-

-

-

-

0

0

0

Decrease (increase) in other accounts receivable and prepaid expenses

119

300

340

510

-323

-137

-136

-164

83

40

138

0

0

0

0

Decrease in deferred revenue

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

Decrease in deferred revenues

-

-

-

-

-

-

-1,065

0

0

0

-

-

-

-

-

Increase (decrease) in trade payables

-448

62

-1,545

-1,745

418

-649

1,010

136

-1,315

-177

-467

0

0

0

0

Increase (decrease) in other accounts payable and accrued expenses

832

-306

-1,098

-1,254

-169

-814

192

1,876

240

93

590

0

0

0

0

Net cash used in operating activities

-20,528

-19,597

-22,242

0

0

0

-

-

-

-

-

-

-

-

-

Cash flows from investing activities:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-22,562

-21,579

0

0

0

0

Proceeds from maturity of investments in restricted cash

-

-

-

-

-

-

308

484

659

718

703

0

0

0

0

Purchase of property and equipment

2,042

1,475

1,710

2,218

2,503

2,467

2,384

1,712

2,016

2,310

1,880

0

0

0

0

Decrease (increase) in long-term deposit

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-2,052

-1,484

-1,661

0

0

0

-

-

-

-

-

-

-

-

-

Cash flows from financing activities:
Investment in other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-1,607

-1,192

0

0

0

0

Proceeds from issuance of convertible preferred shares

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Repayment of loan

-

-

-

-

-

-

234

375

516

563

563

0

0

0

0

Proceeds from options exercised

-

-

-

-

-

-

-

-

-

-

145

0

0

0

-

Proceeds from issuance of Convertible Preferred Shares and warrants, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from issuance of Ordinary Shares, net of issuance costs upon IPO

-

-

-

-

-

-

-

-

-

-

36,159

0

0

0

-

Net increase (decrease) in cash and cash equivalents

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

654

48,455

0

0

0

0

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-25,898

-23,515

25,684

0

0

0

0

Supplemental disclosure of non-cash investing and financing activities:
Purchase of property and equipment

252

467

231

557

-6

71

201

225

129

25

48

0

0

0

0

Conversion of Convertible Preferred Shares into Ordinary Shares

-

-

-

-

-

-

-

-

-

-

47,075

0

0

0

-

Conversion of warrants to purchase Convertible Preferred Shares into Ordinary Shares

-

-

-

-

-

-

-

-

-

-

5,945

0

0

0

-

Non-cash deferred IPO costs

-

-

-

-

-

-

-

-

-

-

933

0

0

0

-

Conversion of Warrants to purchase Convertible Preferred Shares into Warrants to purchase Ordinary Shares

-

-

-

-

-

-

-

-

-

-

87

0

0

0

-

Cash paid during the period:
Cash paid for interest

-

-

-

-

-

-

-

8

14

23

30

0

0

0

0

Cash paid for taxes

0

0

-

0

0

0

-

388

404

346

325

0

0

0

0